NO168530C - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.

Info

Publication number
NO168530C
NO168530C NO873727A NO873727A NO168530C NO 168530 C NO168530 C NO 168530C NO 873727 A NO873727 A NO 873727A NO 873727 A NO873727 A NO 873727A NO 168530 C NO168530 C NO 168530C
Authority
NO
Norway
Prior art keywords
benzocsazone
compounds
preparation
therapeutically active
analogue procedure
Prior art date
Application number
NO873727A
Other languages
English (en)
Other versions
NO873727D0 (no
NO168530B (no
NO873727L (no
Inventor
Friedrich Eiden
Peter Gmeiner
Juergen Schuenemann
Original Assignee
Madaus & Co Dr
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr, Madaus Ag filed Critical Madaus & Co Dr
Publication of NO873727D0 publication Critical patent/NO873727D0/no
Publication of NO873727L publication Critical patent/NO873727L/no
Publication of NO168530B publication Critical patent/NO168530B/no
Publication of NO168530C publication Critical patent/NO168530C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems
NO873727A 1986-09-08 1987-09-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser. NO168530C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863630539 DE3630539A1 (de) 1986-09-08 1986-09-08 Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten

Publications (4)

Publication Number Publication Date
NO873727D0 NO873727D0 (no) 1987-09-07
NO873727L NO873727L (no) 1988-03-09
NO168530B NO168530B (no) 1991-11-25
NO168530C true NO168530C (no) 1992-03-04

Family

ID=6309142

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873727A NO168530C (no) 1986-09-08 1987-09-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.

Country Status (29)

Country Link
US (1) US4859664A (no)
JP (1) JPS6377882A (no)
KR (1) KR910002566B1 (no)
CN (1) CN1020103C (no)
AR (1) AR243190A1 (no)
AT (1) ATA185987A (no)
AU (1) AU590443B2 (no)
BE (1) BE1002121A4 (no)
CH (1) CH675723A5 (no)
CS (1) CS621687A2 (no)
DD (1) DD275052A1 (no)
DE (1) DE3630539A1 (no)
DK (1) DK464487A (no)
ES (1) ES2013322A6 (no)
FI (1) FI88800C (no)
FR (1) FR2603587B1 (no)
GB (1) GB2194786B (no)
GR (1) GR871209B (no)
HU (1) HU203106B (no)
IL (1) IL83156A (no)
IT (1) IT1228437B (no)
NL (1) NL8701938A (no)
NO (1) NO168530C (no)
PL (1) PL154258B1 (no)
PT (1) PT85656B (no)
SE (1) SE8703343L (no)
SU (1) SU1565346A3 (no)
YU (1) YU46068B (no)
ZA (1) ZA876657B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229300A (en) * 1988-06-01 1991-04-26 Smithkline Beckman Corp Substituted-2-ethenyl-3,4,5,6-tetrahydrothieno (4,3,2-cf)(3)benzazepine derivatives and pharmaceutical compositions
DE68917217T2 (de) * 1988-06-01 1994-12-01 Smithkline Beecham Corp Alpha-adrenergische Rezeptorantagonisten.
US4959360A (en) * 1988-06-01 1990-09-25 Smithkline Beecham Corporation α-adrenergic receptor antagonists
US4963547A (en) * 1988-06-01 1990-10-16 Smithkline Beecham Corporation Alpha-andrenergic receptor antagonists and use thereas
CA1320486C (en) * 1988-06-01 1993-07-20 John J. Lafferty .alpha. -adrenergic receptor antagonists
DE4102103A1 (de) * 1991-01-25 1992-08-20 Bayer Ag Substituierte benzoxazepine und benzthiazepine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5248645A (en) * 1992-09-01 1993-09-28 Phillips Petroleum Company Ethylene oligomerization

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124583A (en) * 1964-03-10 Substituted derivatives of
US3118900A (en) * 1962-01-15 1964-01-21 Abbott Lab Substituted derivatives of 3-aza-6, 7-benzo-8-oxa-5-phenylbicyclo[3.3.1]-nonane
US3401166A (en) * 1966-08-01 1968-09-10 Squibb & Sons Inc Therapeutically active benzothiazines
US3446820A (en) * 1967-04-03 1969-05-27 Rexall Drug Chemical Substituted benzoxazocines and intermediates
US3869475A (en) * 1973-04-05 1975-03-04 Yissum Res Dev Co 2,6-methano-benzoxacin compounds
JPS50106985A (no) * 1973-05-08 1975-08-22
US4100277A (en) * 1976-11-08 1978-07-11 American Home Products Corporation 4,1-Benzoxazonine derivatives and process therefor
DK344180A (da) * 1979-08-09 1981-02-10 Glaxo Group Ltd R fremgangsmaade til fremstilling af heterocycliske forbindelse

Also Published As

Publication number Publication date
FR2603587A1 (fr) 1988-03-11
KR910002566B1 (ko) 1991-04-26
NO873727D0 (no) 1987-09-07
FR2603587B1 (fr) 1991-02-01
NL8701938A (nl) 1988-04-05
PL267628A1 (en) 1989-06-12
FI873852A (fi) 1988-03-09
CN87106267A (zh) 1988-04-13
US4859664A (en) 1989-08-22
GB2194786B (en) 1991-01-02
JPS6377882A (ja) 1988-04-08
AU590443B2 (en) 1989-11-02
BE1002121A4 (fr) 1990-07-17
CH675723A5 (no) 1990-10-31
DE3630539A1 (de) 1988-03-10
KR880003945A (ko) 1988-05-31
HUT50180A (en) 1989-12-28
IT1228437B (it) 1991-06-17
AU7816287A (en) 1988-03-10
PL154258B1 (en) 1991-07-31
GR871209B (en) 1987-11-30
NO168530B (no) 1991-11-25
DK464487D0 (da) 1987-09-07
IL83156A0 (en) 1987-12-31
IT8721436A0 (it) 1987-07-24
HU203106B (en) 1991-05-28
JPH0319236B2 (no) 1991-03-14
FI88800B (fi) 1993-03-31
CN1020103C (zh) 1993-03-17
SU1565346A3 (ru) 1990-05-15
FI873852A0 (fi) 1987-09-07
SE8703343L (sv) 1988-03-09
ATA185987A (de) 1994-05-15
DK464487A (da) 1988-03-09
PT85656B (pt) 1990-05-31
AR243190A1 (es) 1993-07-30
GB8716668D0 (en) 1987-08-19
PT85656A (en) 1987-10-01
IL83156A (en) 1992-12-01
FI88800C (fi) 1993-07-12
DD275052A1 (de) 1990-01-10
GB2194786A (en) 1988-03-16
SE8703343D0 (sv) 1987-08-28
ES2013322A6 (es) 1990-05-01
NO873727L (no) 1988-03-09
ZA876657B (en) 1988-03-08
CS621687A2 (en) 1990-09-12
YU46068B (sh) 1992-12-21

Similar Documents

Publication Publication Date Title
NO872946D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO163857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser.
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO166184C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n9-cyklopentyl-substituerte adeninderivater.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO162113C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser.
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO166367C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO166865C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive o-glykosidforbindelser.
NO165843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-6 -substituerte adenosiner.
NO165397C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO167200C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive urinstoff-forbindelser.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO900032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO169963C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO164295C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO873680L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO164172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tienokondenserte forbindelser.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO894949D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater.
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.